These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29594233)

  • 1. Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma - Is PSMA-PET-CT a helpful tool in radiation oncology?
    König L; Hauswald H; Flechtenmacher C; Heller M; Debus J; Haberkorn U; Kratochwil C; Giesel F
    Clin Transl Radiat Oncol; 2017 Dec; 7():79-82. PubMed ID: 29594233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSMA PET Imaging and Therapy in Adenoid Cystic Carcinoma and Other Salivary Gland Cancers: A Systematic Review.
    Tan BF; Tan WCC; Wang FQ; Lechner M; Schartinger VH; Tan DSW; Loke KSH; Nei WL
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential Role of PSMA-Targeted PET in Salivary Gland Malignancies: An Updated Systematic Review.
    Rizzo A; Albano D; Elisei F; Racca M; Dondi F; Annunziata S; Cuzzocrea M; Bertagna F; Treglia G
    Diagnostics (Basel); 2024 Jul; 14(14):. PubMed ID: 39061653
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    de Keizer B; Krijger GC; Ververs FT; van Es RJJ; de Bree R; Willems S
    Nucl Med Mol Imaging; 2017 Dec; 51(4):360-361. PubMed ID: 29242733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.
    Baumann R; Koncz M; Luetzen U; Krause F; Dunst J
    Strahlenther Onkol; 2018 Apr; 194(4):318-324. PubMed ID: 29181556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of
    Siva S; Callahan J; Pryor D; Martin J; Lawrentschuk N; Hofman MS
    J Med Imaging Radiat Oncol; 2017 Jun; 61(3):372-378. PubMed ID: 28116853
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of
    Albisinni S; Artigas C; Aoun F; Biaou I; Grosman J; Gil T; Hawaux E; Limani K; Otte FX; Peltier A; Sideris S; Sirtaine N; Flamen P; van Velthoven R
    BJU Int; 2017 Aug; 120(2):197-203. PubMed ID: 27981732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using
    Zamboglou C; Sachpazidis I; Koubar K; Drendel V; Wiehle R; Kirste S; Mix M; Schiller F; Mavroidis P; Meyer PT; Werner M; Grosu AL; Baltas D
    Radiother Oncol; 2017 Jun; 123(3):472-477. PubMed ID: 28499607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients.
    Natarajan A; Agrawal A; Murthy V; Bakshi G; Joshi A; Purandare N; Shah S; Puranik A; Rangarajan V
    World J Nucl Med; 2019; 18(3):244-250. PubMed ID: 31516367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
    Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
    Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of [
    Frenzel T; Tienken M; Abel M; Berliner C; Klutmann S; Beyersdorff D; Schwarz R; Krüll A; Bannas P
    Strahlenther Onkol; 2018 Jul; 194(7):646-654. PubMed ID: 29572670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years.
    Shakespeare TP; Eggert E; Wood M; Westhuyzen J; Turnbull K; Rutherford N; Aherne N
    Radiother Oncol; 2019 Dec; 141():188-191. PubMed ID: 31668514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists.
    Shakespeare TP
    Radiat Oncol; 2015 Nov; 10():233. PubMed ID: 26582424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, Predictive Factors, and Prediction Nomograms for
    Rauscher I; Düwel C; Haller B; Rischpler C; Heck MM; Gschwend JE; Schwaiger M; Maurer T; Eiber M
    Eur Urol; 2018 May; 73(5):656-661. PubMed ID: 29358059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
    Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
    BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
    J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Thomas L; Kantz S; Hung A; Monaco D; Gaertner FC; Essler M; Strunk H; Laub W; Bundschuh RA
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1170-1178. PubMed ID: 29468311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
    Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.